tenofovir has been researched along with End Stage Liver Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, ML; Cheng, JS; Chien, RN; Lee, KC; Liaw, YF | 1 |
| He, S; Wang, L; Wang, N; Zheng, Y | 1 |
| Chan, AC; Cheung, TT; Chok, KS; Dai, WC; Fung, J; Lai, CL; Lo, CM; Ma, KW; Mak, LY; Seto, WK; She, WH; Sin, SL; Wong, TC; Yuen, MF | 1 |
| Anugwom, CM; Bane, A; Braimoh, GA; Debes, JD; Sultan, A; Wondifraw, Z | 1 |
| Chun, JM; Han, YS; Hur, K; Jang, SY; Kang, MK; Kweon, YO; Lee, HJ; Lee, HW; Lee, YR; Park, JG; Park, SY; Tak, WY | 1 |
| Akarsu, M; Astarcıoğlu, İ; Hakim, GD; Karademir, S; Unek, T | 1 |
| Liu, T; Wang, Y; Zhang, C | 1 |
1 review(s) available for tenofovir and End Stage Liver Disease
| Article | Year |
|---|---|
Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis.
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; End Stage Liver Disease; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome | 2023 |
6 other study(ies) available for tenofovir and End Stage Liver Disease
| Article | Year |
|---|---|
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study.
Topics: Antiviral Agents; Cohort Studies; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome | 2022 |
Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis B.
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Hong Kong; Humans; Liver Function Tests; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Severity of Illness Index; Tenofovir | 2020 |
Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; End Stage Liver Disease; Ethiodized Oil; Ethiopia; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Retrospective Studies; Severity of Illness Index; Sorafenib; Survival Rate; Tenofovir; Treatment Outcome | 2020 |
Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.
Topics: Adult; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; End Stage Liver Disease; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Republic of Korea; ROC Curve; Severity of Illness Index; Tenofovir; Treatment Outcome | 2018 |
The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation.
Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome | 2014 |
Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Guanine; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Organophosphonates; Tenofovir | 2011 |